You are here: Industry Insights > Oxford

News List

Oxford/AstraZeneca vaccine likely to get approval by year-end in UK expresspharma
December 21, 2020
AstraZeneca has said a further 15 million doses of active ingredients are ready and can be filled into vials in a matter of days.
Oxford start-up Base Genomics acquired by Exact Sciences pharmatimes
October 29, 2020
Base Genomics, an Oxford Sciences Innovation (OSI) portfolio company, has been acquired by Exact Sciences for a total consideration of $410m.
Oxford COVID-19 vaccine trials produce robust immune response in elderly: FT expresspharma
October 27, 2020
The COVID-19 vaccine being developed by the University of Oxford and AstraZeneca produces a robust immune response in elderly people, the Financial Times said on Monday, citing early results.
Oxford COVID-19 vaccine follows its programmed genetic instructions, independent analysis finds worldpharmanews
October 23, 2020
The AstraZeneca Oxford COVID-19 vaccine (ChAdOx1 nCoV-19 and also known as AZD1222) now undergoing Phase III clinical trials, has already undergone rigorous testing to ensure the highest standards of quality and safety.
Clinical trials of AstraZeneca-Oxford COVID-19 vaccine candidate resumes in UK expresspharma
September 24, 2020
This is following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so.
UK researchers to test inhaled versions of Oxford and Imperial COVID-19 vaccine candidates expresspharma
September 16, 2020
Delivering the vaccine to the respiratory tract may be a good approach to inducing immune responses in the best place to enable a rapid response after exposure to airborne virus, say researchers.
Oxford COVID-19 vaccine developer cautious on 2020 roll-out expresspharma
July 22, 2020
The experimental vaccine, which has been licensed to AstraZeneca, produced an immune response in early-stage clinical trials, preserving hopes it could be in use by the end of 2020.
Positive news on Oxford/AstraZeneca COVID-19 vaccine could come soon: ITV expresspharma
July 16, 2020
The project has started Phase III of the human trials to assess how the vaccine works in a large number of people over the age of 18, but has yet to report Phase I trial results.
HALIX Enters Collaboration with the University of Oxford for GMP Manufacturing of a COVID-19 Vaccine b3cnewswire
April 23, 2020
HALIX B.V. has joined a consortium of partners under the guidance of the University of Oxford, to provide GMP manufacturing services supporting the large scale production of a COVID-19 vaccine (ChAdOx1 nCoV-19), being developed by the University’s Jenner
Oxford Bio Receives Boehringer Milestone contractpharma
June 27, 2019
Advances immuno-oncology programs leveraging the OGAP target discovery platform.

Previous page 1 2 3 4 Next page